FPN’s Scientific Advisory Board Chairman, Dr. Ahmet Höke, MD, PhD, responds to more questions from our patients about PN and COVID-19 in the second part of our Ask the Expert series.
Leading an FPN peripheral neuropathy support group on Long Island helps Joseph Malkevitch, a Foundation volunteer and supporter, keep an optimistic outlook on life.
The Foundation was eager to connect Joseph with our friends at Brain & Life Magazine earlier this year.
Research shows a potential, treatment for hereditary neuropathy; FPN Research Registry to help validate the findings!
Dr. Stephen Züchner, MD, PhD, of the University of Miami Miller School of Medicine, recently published a research paper that identified a new gene mutation that causes an autosomal, recessive peripheral neuropathy. Dr. Züchner’s team’s research shows that drugs approved for other diseases that target the SORD gene may show promise in treating common forms of hereditary neuropathies, including Charcot-Marie-Tooth (CMT).
Although Congress has been in lockdown for the past two months, it has not refrained from working on its regular agenda. For this reason, the Foundation and its lobbyist continue our advocacy efforts.
Peripheral Neuropathy Awareness Week Recap: May 4–10, 2020
Thank you to everyone who helped the Foundation host another successful awareness week! We couldn’t have done it without you.
But just because the nationally-recognized week is over, that doesn’t mean that we stop our efforts to raise awareness for peripheral neuropathy. You can still help us – in fact, we need everyone who is willing and able. Here are some of our helpful tools which can be shared year round!
The Foundation for Peripheral Neuropathy provides education and support today as we walk toward a cure for tomorrow
Support us in advancing a cure!
FPN is a non-profit organization that is solely funded by our readers.
FPN’s Scientific Advisory Board Chairman, Dr. Ahmet Höke, MD, PhD, responds to more questions from our patients about PN and COVID-19 in the second part of our Ask the Expert series.
.jpg)
working on its regular agenda. For this reason, the Foundation and its lobbyist continue our advocacy efforts.
2020.png)
